Pfizer Long Term Debt vs Total Stockholder Equity Analysis

PFE Stock   12.07  0.06  0.50%   
Pfizer financial indicator trend analysis is much more than just breaking down Pfizer Inc CDR prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pfizer Inc CDR is a good investment. Please check the relationship between Pfizer Long Term Debt and its Total Stockholder Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc CDR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Total Stockholder Equity

Long Term Debt vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pfizer Inc CDR Long Term Debt account and Total Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Pfizer's Long Term Debt and Total Stockholder Equity is 0.56. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Pfizer Inc CDR, assuming nothing else is changed. The correlation between historical values of Pfizer's Long Term Debt and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Pfizer Inc CDR are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Long Term Debt i.e., Pfizer's Long Term Debt and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Long Term Debt

Long-term debt is a debt that Pfizer Inc CDR has held for over one year. Long-term debt appears on Pfizer Inc CDR balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Pfizer Inc CDR balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Pfizer's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pfizer Inc CDR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc CDR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
As of the 29th of November 2024, Selling General Administrative is likely to grow to about 15 B, though Tax Provision is likely to grow to (1.1 B).
 2021 2022 2023 2024 (projected)
Gross Profit50.5B66.0B33.5B49.0B
Total Revenue81.3B100.3B58.5B71.0B

Pfizer fundamental ratios Correlations

0.770.940.92-0.890.860.660.920.90.560.950.930.810.820.140.7-0.43-0.020.730.93-0.640.280.930.990.55-0.15
0.770.840.87-0.880.930.110.830.840.350.620.850.560.40.170.12-0.320.520.220.85-0.720.620.560.660.64-0.57
0.940.840.87-0.820.850.570.880.830.470.850.860.810.680.270.6-0.380.160.570.84-0.610.230.860.90.56-0.08
0.920.870.87-0.890.90.330.980.960.280.830.980.750.560.120.39-0.390.210.420.9-0.680.430.70.860.56-0.42
-0.89-0.88-0.82-0.89-0.98-0.38-0.89-0.83-0.59-0.83-0.91-0.68-0.670.08-0.40.57-0.14-0.54-0.960.86-0.65-0.75-0.83-0.770.5
0.860.930.850.9-0.980.310.90.820.50.80.920.720.58-0.080.32-0.520.210.430.92-0.890.670.690.790.81-0.5
0.660.110.570.33-0.380.310.40.330.710.760.40.630.910.010.98-0.24-0.620.950.48-0.24-0.20.880.760.250.52
0.920.830.880.98-0.890.90.40.90.280.880.980.840.580.030.46-0.470.10.460.86-0.730.380.730.890.63-0.31
0.90.840.830.96-0.830.820.330.90.290.760.920.60.570.310.39-0.290.290.450.9-0.510.350.70.840.36-0.44
0.560.350.470.28-0.590.50.710.280.290.610.370.360.86-0.170.61-0.25-0.310.820.64-0.510.380.750.590.5-0.01
0.950.620.850.83-0.830.80.760.880.760.610.890.90.88-0.110.77-0.43-0.30.80.85-0.710.280.930.980.64-0.01
0.930.850.860.98-0.910.920.40.980.920.370.890.830.63-0.040.43-0.340.080.480.9-0.770.50.740.890.66-0.37
0.810.560.810.75-0.680.720.630.840.60.360.90.830.65-0.230.64-0.32-0.310.560.63-0.70.220.760.850.710.14
0.820.40.680.56-0.670.580.910.580.570.860.880.630.65-0.050.87-0.3-0.430.970.77-0.490.170.950.880.440.13
0.140.170.270.120.08-0.080.010.030.31-0.17-0.11-0.04-0.23-0.050.120.030.580.010.080.52-0.520.140.09-0.570.08
0.70.120.60.39-0.40.320.980.460.390.610.770.430.640.870.12-0.37-0.560.930.49-0.2-0.290.880.790.190.51
-0.43-0.32-0.38-0.390.57-0.52-0.24-0.47-0.29-0.25-0.43-0.34-0.32-0.30.03-0.370.02-0.34-0.450.48-0.14-0.4-0.4-0.470.19
-0.020.520.160.21-0.140.21-0.620.10.29-0.31-0.30.08-0.31-0.430.58-0.560.02-0.530.130.050.22-0.24-0.18-0.11-0.6
0.730.220.570.42-0.540.430.950.460.450.820.80.480.560.970.010.93-0.34-0.530.65-0.34-0.010.910.80.290.26
0.930.850.840.9-0.960.920.480.860.90.640.850.90.630.770.080.49-0.450.130.65-0.730.540.820.880.6-0.46
-0.64-0.72-0.61-0.680.86-0.89-0.24-0.73-0.51-0.51-0.71-0.77-0.7-0.490.52-0.20.480.05-0.34-0.73-0.8-0.51-0.6-0.980.45
0.280.620.230.43-0.650.67-0.20.380.350.380.280.50.220.17-0.52-0.29-0.140.22-0.010.54-0.80.110.20.74-0.79
0.930.560.860.7-0.750.690.880.730.70.750.930.740.760.950.140.88-0.4-0.240.910.82-0.510.110.950.470.13
0.990.660.90.86-0.830.790.760.890.840.590.980.890.850.880.090.79-0.4-0.180.80.88-0.60.20.950.52-0.02
0.550.640.560.56-0.770.810.250.630.360.50.640.660.710.44-0.570.19-0.47-0.110.290.6-0.980.740.470.52-0.31
-0.15-0.57-0.08-0.420.5-0.50.52-0.31-0.44-0.01-0.01-0.370.140.130.080.510.19-0.60.26-0.460.45-0.790.13-0.02-0.31
Click cells to compare fundamentals

Pfizer Account Relationship Matchups

Pfizer fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets167.5B154.2B181.5B197.2B226.5B199.2B
Other Current Liab11.7B12.1B26.7B23.4B20.5B19.6B
Total Current Liabilities37.3B25.9B42.7B42.1B47.8B41.7B
Total Stockholder Equity63.1B63.2B77.2B95.7B89.0B82.8B
Other Liab29.9B26.6B22.6B23.3B21.0B21.3B
Net Tangible Assets(19.0B)(14.7B)2.8B916M1.1B1.1B
Net Debt50.8B36.5B35.1B34.5B68.0B48.6B
Retained Earnings97.7B90.4B103.4B125.7B118.4B114.6B
Accounts Payable3.9B4.3B5.6B6.8B6.7B5.9B
Cash1.3B1.8B1.9B416M2.9B1.7B
Non Current Assets Total134.7B119.2B121.8B145.9B183.2B149.3B
Non Currrent Assets Other4.5B4.6B7.7B13.2B12.5B8.3B
Other Assets18.0B5.8B8.2B16.9B19.4B11.7B
Long Term Debt36.0B35.6B34.8B31.9B60.5B42.4B
Net Receivables9.5B7.9B11.5B11.0B11.2B11.4B
Good Will58.7B49.6B49.2B51.4B67.8B60.5B
Common Stock Shares Outstanding5.5B5.6B5.6B5.6B5.6B4.5B
Short Term Investments8.5B10.4B29.1B22.3B9.8B18.0B
Non Current Liabilities Total66.7B64.8B61.3B59.2B89.4B74.3B
Inventory7.1B8.0B9.1B9.0B10.2B9.3B
Other Current Assets6.5B3.6B3.8B5.0B5.3B4.9B
Other Stockholder Equity(11.6B)(5.3B)(5.9B)(8.3B)(9.5B)(10.0B)
Total Liab104.0B90.8B104.0B101.3B137.2B116.0B
Net Invested Capital115.3B101.5B114.2B130.5B159.9B133.1B
Long Term Investments20.1B20.3B21.5B15.1B15.4B17.4B
Short Long Term Debt16.2B2.7B2.2B2.9B10.3B5.8B
Total Current Assets32.8B35.1B59.7B51.3B43.3B49.9B
Capital Stock485M470M473M476M478M382.4M
Non Current Liabilities Other6.3B6.7B9.7B13.2B16.5B10.7B
Net Working Capital(4.5B)9.1B17.0B9.1B(4.5B)(4.2B)
Intangible Assets35.4B28.5B25.1B43.4B64.9B42.6B
Common Stock468M470M473M476M547.4M517.9M
Property Plant Equipment14.3B15.1B17.7B19.3B22.2B17.5B

Pair Trading with Pfizer

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pfizer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will appreciate offsetting losses from the drop in the long position's value.

Moving against Pfizer Stock

  0.64CYB CymbriaPairCorr
  0.35MNT Royal Canadian MintPairCorr
The ability to find closely correlated positions to Pfizer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pfizer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pfizer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pfizer Inc CDR to buy it.
The correlation of Pfizer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pfizer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pfizer Inc CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pfizer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Pfizer Stock

Balance Sheet is a snapshot of the financial position of Pfizer Inc CDR at a specified time, usually calculated after every quarter, six months, or one year. Pfizer Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Pfizer and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Pfizer currently owns. An asset can also be divided into two categories, current and non-current.